BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30348519)

  • 41. Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
    Cibula D; Akilli H; Jarkovsky J; van Lonkhuijzen L; Scambia G; Meydanli MM; Ortiz DI; Falconer H; Abu-Rustum NR; Odetto D; Klát J; Dos Reis R; Zapardiel I; Di Martino G; Presl J; Laky R; López A; Weinberger V; Obermair A; Pareja R; Poncová R; Mom C; Bizzarri N; Borčinová M; Aslan K; Salcedo Hernandez RA; Fons G; Benešová K; Dostálek L; Ayhan A
    Gynecol Oncol; 2023 Mar; 170():195-202. PubMed ID: 36706646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A; Magistris A; Burger RA; Monk BJ
    Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996).
    Snijders-Keilholz A; Hellebrekers BW; Zwinderman AH; van de Vijver MJ; Trimbos JB
    Radiother Oncol; 1999 May; 51(2):161-7. PubMed ID: 10435808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer.
    Rogers L; Siu SS; Luesley D; Bryant A; Dickinson HO
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007583. PubMed ID: 19821430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.
    Yan X; Li G; Shang H; Lin F; Yang X; Zheng F
    Int J Gynecol Cancer; 2012 Feb; 22(2):286-90. PubMed ID: 22146764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
    Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
    Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does lymph node involvement affect the patterns of recurrence in stage IB cervical cancer?
    Üreyen I; Aksoy Ü; Dündar B; Tapisiz ÖL; Karalök MA; Turan AT; Boran N; Tulunay HG
    Turk J Med Sci; 2014; 44(5):844-52. PubMed ID: 25539556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of radical surgery in women with stage IB2/IIA2 cervical cancer.
    Derks M; Biewenga P; van der Velden J; Kenter GG; Stalpers LJ; Buist MR
    Acta Obstet Gynecol Scand; 2016 Feb; 95(2):166-72. PubMed ID: 26575692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.
    Ziebarth AJ; Smith H; Killian ME; Nguyen NA; Durst JK; Subramaniam A; Kim KH; Leath CA; Straughn JM; Alvarez RD
    Gynecol Oncol; 2012 Jul; 126(1):69-72. PubMed ID: 22484400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
    Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.